Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baloxavir Marboxil for Post-exposure Prophylaxis of Influenza in Chinese Participants
NCT07827599Phase 3Recruiting
- Sponsor
- Roche
- Start
- Oct 2026
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
A Phase 3 trial of baloxavir marboxil in influenza, sponsored by Roche. Started Oct 2026; status: recruiting.
02
Drugs
baloxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on NCT07827599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07827599.